Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patiromer in hyperkalemia with hypertension and diabetic nephropathy
NCT01371747Phase 2Completed
- Sponsor
- Relypsa, Inc.
- Start
- Jun 2011
- Primary completion
- May 2013
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of patiromer in hyperkalemia, sponsored by Relypsa, Inc.. Started Jun 2011; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT01371747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371747.